We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
-0.73%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$32.6B
AUM Growth
+$1.87B
(+6.1%)
Cap. Flow
+$3.25B
Cap. Flow
% of AUM
9.96%
Top 10 Holdings %
Top 10 Hldgs %
9.03%
Holding
3,497
New
825
Increased
816
Reduced
580
Closed
693
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$213M |
| 2 |
AVLR
Avalara, Inc.
AVLR
|
+$183M |
| 3 |
Baxter International
BAX
|
+$173M |
| 4 |
3M
MMM
|
+$172M |
| 5 |
Analog Devices
ADI
|
+$164M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$197M |
| 2 |
TransDigm Group
TDG
|
+$181M |
| 3 |
Apple
AAPL
|
+$148M |
| 4 |
Oracle
ORCL
|
+$133M |
| 5 |
ACC
American Campus Communities, Inc.
ACC
|
+$128M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 11.59% |
| 2 | Technology | 10.77% |
| 3 | Financials | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Healthcare | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
LivaNova
LIVN
$4.33B
| $5.39M | 0.02% |
106,233
-382,080
| -78% | -$22.7M |
|
927
Amylyx Pharmaceuticals
AMLX
$2.63B
| $5.39M | 0.02% |
+191,334
| New | +$4.77M |
|
928
Chevron
CVX
$386B
| $5.38M | 0.02% |
37,468
+16,091
| +75% | +$2.45M |
|
929
Lumen
LUMN
$6.58B
| $5.37M | 0.02% |
737,107
-34,182
| -4% | -$348K |
|
|
IIII
930
DELISTED
INSU Acquisition Corp. III Class A Common Stock
IIII
| $5.37M | 0.02% |
538,724
| – | – |
|
931
BlackLine
BL
$1.63B
| $5.36M | 0.02% |
+89,499
| New | +$6M |
|
|
ALEX
932
DELISTED
Alexander & Baldwin
ALEX
| $5.35M | 0.02% |
322,515
+41,524
| +15% | +$763K |
|
|
ESPR
933
DELISTED
Esperion Therapeutics
ESPR
| $5.33M | 0.02% |
795,671
+783,700
| +6,547% | +$5.38M |
|
934
Xenon Pharmaceuticals
XENE
$6.11B
| $5.32M | 0.02% |
+147,355
| New | +$5.3M |
|
935
US Global Jets ETF
JETS
$827M
| $5.31M | 0.02% |
353,879
+107,576
| +44% | +$1.87M |
|
|
NPAB
936
DELISTED
New Providence Acquisition Corp. II Class A Common Stock
NPAB
| $5.31M | 0.02% |
529,187
| – | – |
|
|
PXD
937
CALL
DELISTED
Pioneer Natural Resource Co.
PXD
| $5.3M | 0.02% |
24,500
+20,700
| +545% | +$4.73M |
|
|
PMT
938
PUT
PennyMac Mortgage Investment
PMT
$824M
| $5.3M | 0.02% |
450,000
| – | – |
|
939
Truist Financial
TFC
$63.9B
| $5.29M | 0.02% |
121,387
-883,384
| -88% | -$42.5M |
|
|
NETC
940
DELISTED
Nabors Energy Transition Corp.
NETC
| $5.28M | 0.02% |
525,020
-275,008
| -34% | -$2.76M |
|
|
CRU
941
DELISTED
Crucible Acquisition Corporation
CRU
| $5.27M | 0.02% |
529,329
| – | – |
|
|
DISH
942
PUT
DELISTED
DISH Network Corp.
DISH
| $5.25M | 0.02% |
+379,400
| New | +$6.71M |
|
943
Blue Owl Capital
OWL
$19.2B
| $5.23M | 0.02% |
+566,823
| New | +$6.3M |
|
944
CALL
Iovance Biotherapeutics
IOVA
$2.94B
| $5.22M | 0.02% |
545,000
+275,400
| +102% | +$3.18M |
|
945
CALL
CME Group
CME
$93.2B
| $5.21M | 0.02% |
29,400
+21,900
| +292% | +$4.33M |
|
|
946
PUT
CME Group
CME
$93.2B
| $5.21M | 0.02% |
29,400
+11,900
| +68% | +$2.35M |
|
947
CALL
Ulta Beauty
ULTA
$23.3B
| $5.17M | 0.02% |
12,900
+9,600
| +291% | +$3.87M |
|
|
948
PUT
Ulta Beauty
ULTA
$23.3B
| $5.17M | 0.02% |
12,900
+9,600
| +291% | +$3.87M |
|
949
PUT
iShares Russell 2000 Growth ETF
IWO
$14.9B
| $5.17M | 0.02% |
+25,000
| New | +$5.63M |
|
950
Marqeta
MQ
$1.62B
| $5.16M | 0.02% |
181,086
+68,883
| +61% | +$2.29M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q3 2022 Portfolio in Review
As of Q3 2022, Balyasny Asset Management held 3,497 positions worth $32.6B, up 6.1% from $30.7B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Balyasny Asset Management deployed $3.25B of net new capital in Q3 2022, opening 825 new positions and adding to 816 existing holdings. Its largest new stake was Baxter International: 2,869,138 shares worth $155M.
By sector, the portfolio is most concentrated in Industrials at 12% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Boeing, an estimated $197M trimmed.
- Balyasny Asset Management's largest Q3 2022 buy was Baxter International: 2,869,138 shares worth $155M.
- Balyasny Asset Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $213M increase.
- Balyasny Asset Management's biggest Q3 2022 reduction was Boeing, cutting an estimated $197M.
- Balyasny Asset Management fully exited TransDigm Group in Q3 2022, selling an estimated $181M.
- Balyasny Asset Management's ten largest holdings make up 9% of its $32.6B portfolio in Q3 2022.
- Balyasny Asset Management opened 825 new positions and closed 693 in Q3 2022.
- Balyasny Asset Management's portfolio value rose 6.1% quarter-over-quarter to $32.6B.
Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.